Olimel N7e

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel N7e, is a mixture of essential and non‑essential amino acids presented as a powder for oral use. It supports metabolic functions and protein synthesis in patients requiring nutritional supplementation.

GNH USA supplies Olimel N7e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

Olimel N7e provides a source of amino acids that act on protein metabolism pathways, useful in several clinical nutrition contexts. - Post‑operative recovery: Helps maintain nitrogen balance and supports tissue repair. - Chronic kidney disease management: Provides a controlled amino acid profile to reduce uremic toxin accumulation. - Inherited metabolic disorders: Supplies specific amino acids required in conditions such as phenylketonuria. - Critical illness nutrition: Contributes to meeting protein targets in intensive care patients. - Malnutrition and cachexia: Aids in restoring lean body mass during prolonged catabolic states.

Adverse reactions to amino acid mixtures are generally mild and related to gastrointestinal tolerance.

Common Side Effects: - Nausea: mild, transient upset stomach. - Diarrhea: loose stools, often resolves with continued use. - Abdominal discomfort: cramping or bloating. - Metallic taste: temporary alteration of taste perception. - Headache: mild, non‑specific.

Serious or Rare Side Effects: - Hyperammonemia: elevated blood ammonia levels, particularly in severe liver disease. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Metabolic acidosis: rare disturbance of acid‑base balance. - Hyperkalemia: elevated potassium levels in susceptible patients. - Severe gastrointestinal bleeding: uncommon but serious. - Electrolyte imbalance: abnormal serum levels of sodium, calcium or magnesium.

When using Olimel N7e, consider patient‑specific factors and monitor relevant clinical parameters. - Renal impairment: adjust dosage and monitor serum electrolytes. - Hepatic dysfunction: watch for signs of hyperammonemia. - Pregnancy and lactation: limited data, use only if clearly needed. - Pediatric use: dosing must be individualized by a specialist. - Concomitant nutrition therapy: avoid excessive protein intake. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Amino acid mixtures can influence the absorption and metabolism of several drug classes.

Major Interactions (Avoid): - Levodopa: reduced absorption leading to diminished therapeutic effect. - MAO‑inhibitors: risk of hypertensive crisis due to tyramine content. - Thyroid hormone replacement: interference with absorption, requiring dose adjustment.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., valproate): possible alteration of plasma amino‑acid levels. - Antibiotics (e.g., tetracycline): chelation reducing oral bioavailability. - Diuretics: potential electrolyte disturbances requiring monitoring.